← Back to search

National Institutes of Health · Department of Health and Human Services

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Open

In short: A grant from National Institutes of Health. Open to many kinds of groups. See who can apply.

Key facts

Deadline
Accepts applications through Nov 16, 2029. Rounds may close sooner: check the notice
Award size
Not stated: see the official notice
Match ?
Not required · Work out your budget and match
Who can apply
Private college or university, Tribal government, Small business, City or town government, State government, Nonprofit with 501(c)(3), Nonprofit without 501(c)(3), Tribal organization, Public college or university, School district, Special district (utility, fire, etc.), County government, Larger business, and others named in the official notice
Where
Anywhere in the U.S., including Tennessee

What changed

  • Status changed from opening soon to open (seen Nov 3, 2026)
  • Deadline moved from Feb 8, 2027 to Nov 16, 2029 (seen Nov 3, 2026)
  • Deadline confirmed by the funder (seen Nov 3, 2026)
  • Opening date moved to Nov 3, 2026 (seen Nov 3, 2026)

Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. Registration is free but can take weeks, so start now, not when the deadline is close. Get-ready checklist

How this fits you

  • Available in Tennessee (nationwide program)
  • No match required

Tell us who you are to see whether you're eligible.

About this grant

The purpose of the Notice of Funding Opportunity (NOFO) is to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, prediction of response or resistance to treatment, cancer prevention and control, as well as pharmacodynamic markers and markers of toxicity. Utilizing either a phased UH2/UH3 or a standalone UH3 mechanism, funding will facilitate laboratory optimization and clinical validation of assays that work on human samples and address a clearly defined cancer-related clinical need within a well-specified intended use.

Who can apply, from the official notice

Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility. · Foreign Organizations/International Collaborations: Non-domestic (non-U. · S.) Entities (Foreign Organizations) are not eligible to apply. · Non-domestic (non-U. · S.) components of U. · S. Organizations are not eligible to apply. · Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

View on Grants.gov Add deadline to my calendar

Ask a partner for a letter

Your schedule, working back from the deadline

  1. Nov22
    Check that your SAM.gov registration is active (or start it now)
    Grants.gov: allow up to 10 business days for SAM registration, weeks or months if information isn't verified. It must be renewed every year. Grants.gov
  2. Oct26
    Ask partners for letters of support or commitment
    Suggested: partners need about three weeks to write and sign letters.
  3. Nov9
    Finish a complete draft for a final review
    Suggested: leave about a week for someone else to read the draft.
  4. Nov14
    Submit
    Grants.gov: submit at least 24–48 hours before the deadline: uploads fail, systems slow down, errors need fixing. Grants.gov blog
  5. Nov16
    Deadline
    From the funder.

Save this grant to put these dates in My grants and your private calendar.

More from National Institutes of Health

About the federal program

National Cancer Institute Research - Research Projects
Program number 93.CA1 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Grant, cooperative agreement (a grant with close agency involvement)

How applications are judged

The major elements in evaluating applications include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following will be considered in making funding decisions: 1) Scientific and technical merit of the proposed project as determined by scientific peer review; 2) Availability of funds; and 3) Relevance of the proposed project to program priorities.

Match

None required (federal program listing).

This program on SAM.gov

Something wrong on this page? Tell us
What's wrong?

Source: Federal grants from Grants.gov · the official federal record. Last checked by GrantMe Nov 22, 2026.

Reference numbers: official notice number PAR-28-042 · program number 93.CA1